$COCO
Vita Coco Company, Inc.

2024 Q4 Form 10-Q Financial Statement

#000148298124000127 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $132.9M
YoY Change -3.74%
Cost Of Revenue $81.34M
YoY Change -0.67%
Gross Profit $51.56M
YoY Change -8.21%
Gross Profit Margin 38.8%
Selling, General & Admin $30.97M
YoY Change -5.15%
% of Gross Profit 60.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $196.0K
YoY Change 22.5%
% of Gross Profit 0.38%
Operating Expenses $30.97M
YoY Change -5.15%
Operating Profit $20.60M
YoY Change -12.44%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit 0.0%
Other Income/Expense, Net $5.018M
YoY Change -215.44%
Pretax Income $25.61M
YoY Change 33.57%
Income Tax $6.362M
% Of Pretax Income 24.84%
Net Earnings $19.25M
YoY Change 26.95%
Net Earnings / Revenue 14.48%
Basic Earnings Per Share $0.34
Diluted Earnings Per Share $0.32
COMMON SHARES
Basic Shares Outstanding 56.73M shares 56.78M shares
Diluted Shares Outstanding 59.31M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.7M
YoY Change 65.13%
Cash & Equivalents $156.7M
Short-Term Investments
Other Short-Term Assets $30.55M
YoY Change 36.38%
Inventory $64.91M
Prepaid Expenses
Receivables $78.60M
Other Receivables $0.00
Total Short-Term Assets $330.8M
YoY Change 33.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.440M
YoY Change 9.66%
Goodwill $7.791M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.019M
YoY Change 17.11%
Total Long-Term Assets $22.39M
YoY Change 5.74%
TOTAL ASSETS
Total Short-Term Assets $330.8M
Total Long-Term Assets $22.39M
Total Assets $353.1M
YoY Change 31.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.25M
YoY Change 45.97%
Accrued Expenses $64.91M
YoY Change 26.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $10.00K
YoY Change
Total Short-Term Liabilities $100.7M
YoY Change 36.01%
LONG-TERM LIABILITIES
Long-Term Debt $5.000K
YoY Change
Other Long-Term Liabilities $318.0K
YoY Change -82.55%
Total Long-Term Liabilities $318.0K
YoY Change -82.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $100.7M
Total Long-Term Liabilities $318.0K
Total Liabilities $101.0M
YoY Change 33.15%
SHAREHOLDERS EQUITY
Retained Earnings $153.3M
YoY Change 63.16%
Common Stock $170.4M
YoY Change 7.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $252.1M
YoY Change
Total Liabilities & Shareholders Equity $353.1M
YoY Change 31.54%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $19.25M
YoY Change 26.95%
Depreciation, Depletion And Amortization $196.0K
YoY Change 22.5%
Cash From Operating Activities $9.325M
YoY Change -78.77%
INVESTING ACTIVITIES
Capital Expenditures $435.0K
YoY Change 987.5%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$435.0K
YoY Change 770.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.802M
YoY Change -156.49%
NET CHANGE
Cash From Operating Activities 9.325M
Cash From Investing Activities -435.0K
Cash From Financing Activities -1.802M
Net Change In Cash 7.088M
YoY Change -84.94%
FREE CASH FLOW
Cash From Operating Activities $9.325M
Capital Expenditures $435.0K
Free Cash Flow $8.890M
YoY Change -79.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
001-40950
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
161414000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50086000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
50757000 usd
CY2023Q4 coco Supplier Advances Current
SupplierAdvancesCurrent
1521000 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
3876000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63135453 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56899253 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
631000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-649000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285682000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132906000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
138064000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81344000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81893000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231244000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
246542000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
51562000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
56171000 usd
us-gaap Gross Profit
GrossProfit
157476000 usd
us-gaap Gross Profit
GrossProfit
140926000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30967000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
550000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4011000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-426000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
805000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-317000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20035000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14738000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53387000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39539000 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3959000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001482981
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56731939 shares
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2257000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
64905000 usd
CY2024Q3 coco Supplier Advances Current
SupplierAdvancesCurrent
1265000 usd
CY2024Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
1299000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27986000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24160000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
330761000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
262937000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2440000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2136000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1213000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
13000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
318000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
647000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
101027000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
83245000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63472285 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56731839 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
635000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
169736000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153324000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100742000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
156000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6740446 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6236200 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
71731000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
59701000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
252120000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
202437000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353147000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32649000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87941000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89855000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20595000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23522000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69535000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
51071000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
31000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5018000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4347000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1114000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25613000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19175000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69137000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49957000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6362000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16555000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10101000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19251000 usd
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56769410 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56493757 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56688362 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56290195 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59314805 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59271757 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59099179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58494045 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19251000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
15164000 usd
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
784000 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
The Vita Coco Company, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3713156
dei City Area Code
CityAreaCode
212
dei Entity Address Address Line1
EntityAddressAddressLine1
250 Park Avenue South
dei Entity Address Address Line2
EntityAddressAddressLine2
Seventh Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
dei Trading Symbol
TradingSymbol
COCO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Local Phone Number
LocalPhoneNumber
206-0763
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 Per Share
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156706000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132537000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2486000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78600000 usd
CY2024Q3 coco Supplier Advances Noncurrent
SupplierAdvancesNoncurrent
2732000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6756000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
7791000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7791000 usd
CY2023Q4 coco Supplier Advances Noncurrent
SupplierAdvancesNoncurrent
2820000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1406000 usd
CY2023Q4 us-gaap Assets
Assets
285682000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59533000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4533000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
100704000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82585000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1211000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
472000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-430000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6749000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
648000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2019000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1843000 usd
CY2024Q3 us-gaap Assets
Assets
353147000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31253000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21826000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64908000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
10000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2592000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1876000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-398000 usd
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
540000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
503000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-19000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-665000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
255000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6649000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7126000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
363000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
764000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
966000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26910000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37234000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13974000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33815000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2585000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5215000 usd
coco Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities Noncurrent
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesNoncurrent
13667000 usd
coco Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities Noncurrent
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesNoncurrent
17361000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35977000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70003000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
849000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
533000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-528000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1676000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5915000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-10000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-18000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12030000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10364000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5897000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25097000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
75584000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132867000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19629000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157964000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95213000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
1258000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
824000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5026000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1105000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
15164000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
540000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
503000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-19000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-665000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
255000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6649000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7126000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
363000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
764000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
966000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26910000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37234000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13974000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33815000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2585000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5215000 usd
coco Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities Noncurrent
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesNoncurrent
13667000 usd
coco Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities Noncurrent
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesNoncurrent
17361000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35977000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70003000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
849000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
533000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-849000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1676000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5915000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-10000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-18000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12030000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10364000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5897000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25097000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
75584000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132867000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19629000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157964000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95213000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
1258000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
328000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. Additionally, uncertainty in the macroeconomic environment resulting from current geopolitical and economic instability (including the effects of current wars and other international conflicts) and the high interest rate and inflationary cost environment make estimates and assumptions difficult to calculate with precision. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the condensed consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, determining the accounts receivables reserve, assessing goodwill for impairment, determining the value of trade promotions, and assessing the realizability of deferred income taxes. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality institutions, which may include banks, financial institutions and investment firms, and invest daily or reserve operating cash in money market funds, government securities, bank obligations, municipal securities or other investment vehicles with short-term maturities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Substantially all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchases from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers in aggregate represented 48% and 51% of total net sales for the nine months ended September 30, 2024 and 2023, respectively. In addition, the two customers in aggregate also accounted for 37% and 43% of total accounts receivable as of September 30, 2024 and December 31, 2023, respectively. The Company has not experienced credit issues with these customers. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span> regarding additional information on our major customers.
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132906000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
138064000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
328000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. Additionally, uncertainty in the macroeconomic environment resulting from current geopolitical and economic instability (including the effects of current wars and other international conflicts) and the high interest rate and inflationary cost environment make estimates and assumptions difficult to calculate with precision. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the condensed consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, determining the accounts receivables reserve, assessing goodwill for impairment, determining the value of trade promotions, and assessing the realizability of deferred income taxes. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality institutions, which may include banks, financial institutions and investment firms, and invest daily or reserve operating cash in money market funds, government securities, bank obligations, municipal securities or other investment vehicles with short-term maturities.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Substantially all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchases from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers in aggregate represented 48% and 51% of total net sales for the nine months ended September 30, 2024 and 2023, respectively. In addition, the two customers in aggregate also accounted for 37% and 43% of total accounts receivable as of September 30, 2024 and December 31, 2023, respectively. The Company has not experienced credit issues with these customers. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span> regarding additional information on our major customers.
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132906000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
138064000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3753000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3360000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
61152000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
47397000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
64905000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
50757000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
7791000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7791000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
15000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
26000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
10000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
13000 usd
CY2024Q3 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2023Q4 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2024Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3753000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3360000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
61152000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
47397000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
64905000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
50757000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
7791000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7791000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
15000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
26000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
10000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
13000 usd
CY2024Q3 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2023Q4 us-gaap Litigation Reserve
LitigationReserve
0 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2592000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3959000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-610000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1909000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
185000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4552000 usd
coco Number Of Votes
NumberOfVotes
1 vote
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6740446 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6236200 shares
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12030000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
773000 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
27196000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2592000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3959000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-610000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1909000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
185000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4552000 usd
coco Number Of Votes
NumberOfVotes
1 vote
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6740446 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6236200 shares
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12030000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
773000 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
27196000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2141000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2862000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6649000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7126000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2141000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2862000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6649000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7126000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6362000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4011000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16555000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10101000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
106000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
106000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19251000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
15164000 usd
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56769410 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56493757 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56688362 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56290195 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2545395 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2778000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2410817 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2203850 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59271757 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59099179 shares
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6362000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4011000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16555000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10101000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
106000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
106000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
19251000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
15164000 usd
us-gaap Net Income Loss
NetIncomeLoss
52582000 usd
us-gaap Net Income Loss
NetIncomeLoss
39856000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56769410 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56493757 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56688362 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56290195 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2545395 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2778000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2410817 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2203850 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59314805 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59271757 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59099179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58494045 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58494045 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132906000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
138064000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
51562000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
56171000 usd
us-gaap Gross Profit
GrossProfit
157476000 usd
us-gaap Gross Profit
GrossProfit
140926000 usd
CY2024Q3 us-gaap Assets
Assets
353147000 usd
CY2023Q4 us-gaap Assets
Assets
285682000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
51562000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
56171000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132906000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
138064000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
51562000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
56171000 usd
us-gaap Gross Profit
GrossProfit
157476000 usd
us-gaap Gross Profit
GrossProfit
140926000 usd
CY2024Q3 us-gaap Assets
Assets
353147000 usd
CY2023Q4 us-gaap Assets
Assets
285682000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
51562000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
56171000 usd
us-gaap Gross Profit
GrossProfit
157476000 usd
us-gaap Gross Profit
GrossProfit
140926000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30967000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32649000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87941000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89855000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20595000 usd
us-gaap Gross Profit
GrossProfit
157476000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30967000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87941000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89855000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23522000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69535000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
51071000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2592000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3959000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5896000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
550000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1211000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
472000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-430000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1876000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
824000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5026000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1105000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
31000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25613000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19175000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69137000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2440000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2136000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23522000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
69535000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
51071000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2592000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3959000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1758000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
550000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1211000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
472000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-430000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1876000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
824000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5026000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1105000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
31000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25613000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19175000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69137000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49957000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
388720000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
387468000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2440000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2136000 usd
CY2023 coco Sale Of Stock Number Of Secondary Offerings
SaleOfStockNumberOfSecondaryOfferings
2 offering
CY2023Q2 coco Expenses Incurred Reimbursement Waived
ExpensesIncurredReimbursementWaived
140000 usd
CY2023Q4 coco Expenses Incurred Reimbursement Waived
ExpensesIncurredReimbursementWaived
324000 usd
CY2023Q2 coco Expenses Incurred Reimbursement Waived
ExpensesIncurredReimbursementWaived
140000 usd
CY2023Q4 coco Expenses Incurred Reimbursement Waived
ExpensesIncurredReimbursementWaived
324000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001482981-24-000127-index-headers.html Edgar Link pending
0001482981-24-000127-index.html Edgar Link pending
0001482981-24-000127.txt Edgar Link pending
0001482981-24-000127-xbrl.zip Edgar Link pending
coco-20240930.htm Edgar Link pending
coco-20240930.xsd Edgar Link pending
coco20240930-10qexx321ceo.htm Edgar Link pending
coco20240930-10qexx322cfo.htm Edgar Link pending
coco20240930-exx311martinr.htm Edgar Link pending
coco20240930-exx312coreyba.htm Edgar Link pending
coco-20240930_cal.xml Edgar Link unprocessable
coco-20240930_def.xml Edgar Link unprocessable
coco-20240930_pre.xml Edgar Link unprocessable
coco-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coco-20240930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending